Seroflo is a combination of a long acting beta2-agonist (salmeterol) and an inhaled corticoseroid (fluticasone), approved for the treatment of asthma and COPD. It is available as an inhaler, Autohaler & Rotacaps, to be used with Rotahaler and Revolizer and as Multihaler. This brand card is a comprehensive representation of key information related to Seroflo, including indication, dosage and administration and contraindications
